Thursday, 16 July 2009
Nick Evans
CLINUVEL says it will send its lead solar-protective compound into a larger trial in solar urticaria after announcing positive results of a small pilot trial in the disease this week.
You are not logged in or not authorised to view this page.
Get Your FREE 30 Day Trial Now!
|
|
|
OR
Click here to read the rest of today's news stories.
| 
